Ubs Oconnor LLC Uro Gen Pharma Ltd. Transaction History

Ubs Oconnor LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	BUY	$35.47 - $54.55 $234,066 - $359,975	6,599 Added 40.61%	22,849 $0
Q4 2018 Feb 15, 2019	SELL	$38.35 - $50.39 $245,785 - $322,949	-6,409 Reduced 28.28%	16,250 $699,000
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $1.1 Million - $1.48 Million	22,659 New	22,659 $0

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.